Skip to main content
PMC home page
BMC Ophthalmology logoLink to BMC Ophthalmology
. 2005 Sep 13;5:22. doi: 10.1186/1471-2415-5-22

Relationship between visual field loss and contrast threshold elevation in glaucoma

CM Tochel 1, JS Morton 1, JL Jay 2, JD Morrison 1,✉
PMCID: PMC1249580  PMID: 16159386

Abstract

Background

There is a considerable body of literature which indicates that contrast thresholds for the detection of sinusoidal grating patterns are abnormally high in glaucoma, though just how these elevations are related to the location of visual field loss remains unknown. Our aim, therefore, has been to determine the relationship between contrast threshold elevation and visual field loss in corresponding regions of the peripheral visual field in glaucoma patients.

Methods

Contrast thresholds were measured in arcuate regions of the superior, inferior, nasal and temporal visual field in response to laser interference fringes presented in the Maxwellian view. The display consisted of vertical green stationary laser interference fringes of spatial frequency 1.0 c deg-1 which appeared in a rotatable viewing area in the form of a truncated quadrant extending from 10 to 20° from fixation which was marked with a central fixation light. Results were obtained from 36 normal control subjects in order to provide a normal reference for 21 glaucoma patients and 5 OHT (ocular hypertensive) patients for whom full clinical data, including Friedmann visual fields, had been obtained.

Results

Abnormally high contrast thresholds were identified in 20 out of 21 glaucoma patients and in 2 out of 5 OHT patients when compared with the 95% upper prediction limit for normal values from one eye of the 36 normal age-matched control subjects. Additionally, inter-ocular differences in contrast threshold were also abnormally high in 18 out of 20 glaucoma patients who had vision in both eyes compared with the 95% upper prediction limit. Correspondence between abnormally high contrast thresholds and visual field loss in the truncated quadrants was significant in 5 patients, borderline in 4 patients and absent in 9 patients.

Conclusion

While the glaucoma patients tested in our study invariably had abnormally high contrast thresholds in one or more of the truncated quadrants in at least one eye, reasonable correspondence with the location of the visual field loss only occurred in half the patients studied. Hence, while contrast threshold elevations are indicative of glaucomatous damage to vision, they are providing a different assessment of visual function from conventional visual field tests.

Background

The visual field loss caused by glaucoma has been divided into 5 stages ranging from relative defects in sensitivity to almost complete visual loss [1]. The pattern of loss which alerts awareness of the disease, however, is often an arcuate scotoma occurring with approximately equal frequency in the superior or inferior hemifield within 20 degrees of the fovea and with or without a nasal step. These losses are generally detected in the clinical environment by visual field tests involving presentation of spots of light within a hemi-spherical dome at various locations within the central visual field. However, by the time visual field defects are detected, considerable loss of retinal ganglion cells may already have occurred, as exemplified by the case of a glaucoma suspect who, despite an absence of local field defects prior to death, showed ganglion cell losses post-mortem of 63% and 44% in left and right retinae, respectively [2]. Accordingly, there has been an impetus to develop alternative tests to visual field testing capable of detecting glaucoma at earlier stages. One such test is the measurement of contrast sensitivity in response to sinusoidal grating patterns generated by a variety of methods-oscilloscope, TV or computer monitor, printed paper, laser interferometry, or Snellen letters. The most usual protocol has involved measurements of contrast sensitivity in response to foveal viewing of the display [3-14], though more involved studies have additionally determined contrast sensitivities at peripheral locations in the visual field [15-22]. The consensus has been, with one exception [13], that contrast sensitivity in response to low spatial frequencies is impaired in glaucoma, leading to strong advocacy of its usefulness in glaucoma screening. While most studies reported the results of visual field tests, correlations between impaired contrast sensitivity and the location of visual field loss were generally not undertaken. In the one case in which this was done on a limited scale [17], contrast sensitivity deficits were described as occurring in both the visual hemifield showing no visual loss and the hemifield which did show visual loss.

We have therefore set out to answer the question whether regions of glaucomatous visual field loss are associated with elevations of contrast threshold which was employed rather than its reciprocal, the contrast sensitivity. For this purpose, we have designed a streamlined method of measuring contrast thresholds at different peripheral locations in the visual field based on the advantages offered by viewing laser interference fringes in the Maxwellian view. This provides a large visual field which can be viewed without the need for refraction of the viewer and has a sense of proximity, rather than the unavoidable remoteness of an externally generated grating display. Our results were then compared with visual field data obtained in the conventional manner. A preliminary report of our results has been made previously [23].

Methods

Patients

The experiments were undertaken with the informed consent of the participants and with the approval of the Ethics Committee of the North Glasgow University Hospitals NHS Trust and were performed in conformity with the Declaration of Helsinki. All subjects and patients underwent the Snellen test to determine their best visual acuity with refraction if necessary.

A total of 26 patients ages 37 to 83 yr (mean 69 ± 10 S.D. yr) were recruited from the Tennent Institute of Ophthalmology, Gartnavel General Hospital. They were diagnosed according to their intra-ocular pressure (IOP) determined by applanation tonometry, the appearance of the optic disc on ophthalmoscopic examination and the extent of visual field loss determined with the Friedmann Visual Field Analyzer Mark II (Clement Clarke International Ltd., London). Twenty one patients were diagnosed as having glaucoma (Table 1): the most common condition was primary open angle glaucoma (POAG) in which IOP exceeded 22 mmHg on at least 2 occasions before treatment, there was cupping of the optic disc and visual field defects characteristic of glaucoma were present. Normal pressure glaucoma (NPG) was diagnosed according to the same criteria as POAG except that IOP was less than 22 mmHg. In addition, one patient had each of primary chronic angle closure glaucoma, post-traumatic glaucoma and sarcoid-induced glaucoma. Within the glaucoma group, since 6 patients had a fellow eye which showed no visual field defects or definite pathological cupping of the optic disc and had an IOP of less than 22 mmHg, these eyes were designated normal, though were not used as controls. The 5 ocular hypertensives (OHT) were defined on the basis of an IOP which exceeded 21 mmHg but with no visual field loss and were subdivided into those with and without pathological cupping of the optic disc (Table 1). All patients were selected on the basis of having stable visual fields through being superimposable in terms of their position, extent and depth, tested usually on a six monthly basis over the 2 years preceding the study. Five patients who were subsequently retested over intervals of 1 day to 6 months showed reproducible visual fields.

Table 1.

Clinical data for glaucoma and OHT patients

Pat no. Age (yr) LE Condition LE VA LE VF loss LE CTmax RE Condition RE VA RE VF loss RE CTmax I-O diff R2
1 72 POAG 6/5 74% 0.051 POAG 6/4 7% 0.023 0.025 79%*
2 73 POAG 6/6 60% 0.098 POAG 6/7.5 51% 0.168 0.045 0%°
3 67 POAG 6/6 4% 0.099 NPG 6/9 53% 0.107 0.004 48%+
4 76 POAG 6/6 7% 0.075 POAG 6/7.5 44% 0.078 0.001 1%°
5 71 POAG 6/6 36% 0.142 POAG 6/6 30% 0.067 0.045 0%°
6 66 POAG 6/6 17% 0.075 POAG 6/12 7% 0.091 0.014 -25%°
7 77 POAG 6/24 55% 0.055 POAG 6/6 67% 0.044 0.012 14%°
8 68 POAG 6/6 23% 0.069 normal 6/5 4% 0.049 0.019 55%*
9 75 POAG 6/9 44% 0.102 normal 6/5 1% 0.041 0.034 85%*
10 72 normal 6/6 2% 0.023 POAG 6/9 42% 0.031 0.006 47%+
11 37 POAG 6/18 14% 0.089 blind nil 100% n/s na na
12 83 POAG pxf 6/9 1% 0.066 POAG pxf 6/9 51% n/s na na
13 83 POAG pxf 6/18 69% 0.058 POAG pxf 6/12 46% 0.074 0.025 -24%°
14 74 POAG pxf 6/5 26% 0.067 OHT 6/6 3% 0.056 0.008 9%°
15 73 NPG 6/5 17% 0.055 NPG 6/5 47% 0.033 0.014 0%°
16 76 NPG 6/9 18% 0.150 NPG 6/12 47% 0.060 0.021 46%+
17 73 NPG 6/9 53% 0.048 normal 6/9 4% 0.027 0.010 49%+
18 54 RD 6/12 2% 0.046 NPG 6/5 41% 0.083 0.023 85%*
19 61 PCACG 6/9 11% 0.078 ACG 6/9 3% 0.072 0.012 na
20 79 PTG 6/9 55% 0.147 normal 6/9 6% 0.077 0.055 26%°
21 55 normal 6/6 7% 0.044 SIG 6/6 52% 0.058 0.017 73%*
22 70 OHT 6/5 0%(2%) 0.031 OHT 6/5 0% (6%) 0.018 0.002 na
23 78 OHT 6/5 0% (7%) 0.022 OHT 6/9 3% (8%) 0.033 0.0064 na
24 57 OHT 6/5 6% (13%) 0.054 OHT 6/5 4%(13%) 0.051 0.0006 na
25 62 OHT 6/5 2% (2%) 0.034 OHT pdc 6/12 4% (6%) 0.042 0.010 na
26 72 A OHT pdc 6/60 8% (29%) 0.155 OHT pdc 6/12 8% (35%) 0.059 0.068 na
Open in a new tab

Pat no. Patient number, LE left eye, RE right eye, A amblyopic, CTmax highest contrast threshold value (to be compared against the upper prediction limit of 0.045), I-O diff inter-ocular difference (to be compared against the upper prediction limit of 0.006), NPG normal pressure glaucoma, OHT ocular hypertensive, na not applicable, n/s not seen, PCACG primary chronic angle closure glaucoma, pdc pathological cupping of optic disc, POAG primary open angle glaucoma, PTG post-traumatic glaucoma, pxf pseudoexfoliation, RD retinal detachment, SIG sarcoid-induced glaucoma, VA visual acuity, VF visual field. Negative R2 values denote inverse relationship. *p < 0.05, +0.05 <p < 0.10, °p > 0.10. Some eyes denoted normal show visual field loss due to the blind spot while some glaucomatous eyes showing minimal visual loss had additional loss either more peripheral or more central to the truncated quadrant. OHT patients also show visual field loss score in parenthesis at 12 months follow-up examinations.

As controls, we examined 36 non-glaucoma subjects ages 48–78 yr (mean 62 ± 8 S.D. yr.) who were recruited from within the University and from personal acquaintances. They were deemed to be normal on the basis of a reported absence of visual problems, a Snellen acuity of 6/6 or better in each eye and a report of normal vision from a recent visit to their optometrist. While 28 subjects had 2 normal eyes, 8 subjects had one normal eye and a non-glaucomatous problem in the fellow eye, which is dealt with separately. Of the 36 subjects, 19 were emmetropic while the remainder had refractive errors ranging from +1.50 DS to -7.00 DS with astigmatism of up to +5.00 DC and all were presbyopic to varying extents. Twenty three subjects ages 55–78 yr, including all subjects above 69 yr, were also examined with the Central 24-2 threshold test with the Humphrey II Visual Field Analyzer model 750 (Humphrey Instruments, San Leandro, CA, USA) to which we had ready access at times convenient to our subjects.

Apparatus

Contrast thresholds were measured with a modification of a laser interferometer described previously [24,25] and is shown schematically in Figure 1. Monochromatic green light (λ = 543 nm) from a 0.95 mW He-Ne laser (Uniphase 1652P) was passed through a spatial filter (SF), a -10 DS lens (L1) to expand the beam and a +10 DS lens (L2) to collimate the beam. The beam was then divided by a 2 inch cube beamsplitter (B1), the 2 beams reflected from λ/20 front silvered mirrors (M1 and M2) and recombined by a second 2 inch cube beamsplitter (B2). The two beams were equated in intensity by the neutral density filter N1 and the polarization shift caused by the beamsplitters was compensated by the rotatable sheet polarizer (P1, extinction = 10-4). The combined beams were passed through a second polarizer (P2) to sharpen the polarization prior to combination at the plate beamsplitter B3 with the background beam which consisted of non-coherent light from a tungsten filament microscope lamp. The latter beam was passed through heat absorbing filters, a green interference filter (C, peak λ = 546 nm), a polarizer (P3) to polarize the light at 90° to the laser beams and a neutral density filter (N2) to equate the intensity to that of the laser beams. The combined laser and background beams were passed through a rotatable polarizer of 2 inch diameter (P4, Coherent-Ealing 22-9161). The emergent beam passed through an iris diaphragm (I) which controlled the overall field size, an aperture consisting of a rotatable truncated quadrant (Q) and the Maxwellian lens assembly which consisted of 38 mm diameter +20 DS plano-convex and +32 DS biconvex high refractive index lenses mounted in the same housing as the rotatable aperture. The total power of the Maxwellian lens assembly was +42 DS. The subject or patient looked into the Maxwellian lens with the chin supported by a chin rest. The observed visual display consisted of an attenuated green central fixation light of subtense 2° and the truncated quadrant which was rotatable to the 4 chosen visual field positions viz. temporal, superior, inferior and nasal, as shown for right eye viewing in Figure 2.

Figure 1.

Figure 1

Open in a new tab

Schematic representation of optical apparatus used to generate vertical sinusoidal laser interference fringes which are observed in the Maxwellian view. Abbreviations: A aperture, B beam splitter, C interference filter, I iris diaphragm, L lens, M front silvered mirror, N neutral density filter, P polarizer, SF spatial filter. Further explanation is given in Methods.

Figure 2.

Figure 2

Open in a new tab

Schematic representation of the truncated quadrants in the temporal, superior, inferior and nasal positions as seen by the right eye. The central fixation light was of subtense 2 deg and the truncated quadrant extended from 10–20 deg. The sinusoidal interference fringe pattern had a spatial frequency of 1.0 c deg-1.

The truncated quadrant extended from 10° to 20° from the central fixation point. The angular dimensions were calibrated from determination of the location of the nasal and temporal margins of the blind spot from the axis of fixation. These were determined first in angular subtenses for viewing a sheet of graph paper from 25 cm. The linear dimensions of the blind spot from the axis of fixation were then obtained for viewing a needle mounted on a micrometer, coplanar with the iris diaphragm, through the Maxwellian lens. The factor to convert linear dimensions into angular dimensions was then used to convert the linear dimension of the Maxwellian display into angular subtenses. The procedure was undertaken in both eyes in 3 subjects with close agreement between the results.

By translation of mirror M1 to increase the pathlength of the laser beam reflected from M1, interference fringes were generated at a spatial frequency directly related to the pathlength difference. By adjustment, the spatial frequency was set to 1.0 c deg-1 which is readily detected for peripheral viewing at our eccentricities [26]. The contrast of the display was varied by rotation of the polarizer P4, since contrast is proportional to sin2θ where θ is the angle of rotation from the position of zero contrast. The intensities of the laser beam and background beam were equated using a UDT S370 Optometer at the position of the eye. Likewise, the intensities of the 4 quadrants were also equalized. The final viewing intensity was determined psychophysically to be 3.2 log units above foveal threshold.

Contrast threshold determinations

Prior to the determinations, each subject or patient was given a standard explanation with the aid of diagrams as to the nature of the test, which was then carried out under standardized subdued illumination. The subject or patient viewed the display through the Maxwellian lens without external refraction. With the direction of gaze determined by the central fixation spot, the subject or patient increased the contrast of the grating display in the peripherally-located truncated quadrant until the pattern became just visible and no more. This gives results for contrast thresholds similar to those for the more time consuming 50% of seeing [27]. The angle of rotation was recorded and readings repeated. First, the subject or patient had practice runs with the truncated quadrant in each of its 4 positions. This was then followed by 6 contrast threshold determinations for each of the 4 truncated quadrant positions for each eye in turn. The tests including the preliminary Snellen test and explanation took 20–40 min to complete. Repeat determinations in 2 normal subjects and one glaucoma patients on different days confirmed the consistency of the contrast threshold values. The determinations for the glaucoma patients were undertaken prior to the release of the visual field charts for analysis and the time interval between the tests ranged from the same day to 36 weeks (mean 64 ± 55 S.D. days).

Data analysis

Statistical analyses were undertaken with the Minitab statistical package [28]. The basic method of analysis involved the calculation of 95% prediction limits for the contrast thresholds and for the inter-ocular differences in contrast threshold between companion normal eyes, against which the results for the glaucoma patients were compared. After conversion of the data to cumulative probabilities, the sensitivity (the percentage of correctly classified glaucoma patients) was plotted against 1 – specificity (the percentage of incorrectly classified normal subjects) to obtain the Receiver Operating Characteristic (ROC) curve [29,30]. The area under the ROC curve is a measure of the sensitivity over a range of criterion levels and varies from 0.5 when there is an equal likelihood of glaucoma patients and normal subjects exceeding the specified criterion to 1.0 when there is perfect discrimination of glaucoma patients from normal subjects.

Comparisons between the mean contrast threshold for each truncated quadrant against visual field loss were undertaken by linear regression analysis after quantifying the visual field loss from the patient's Friedmann visual field chart [31]. A template containing an aperture corresponding to the dimensions of the truncated quadrant was laid over the Friedmann visual field chart and the following scores allocated to each point tested according to whether the point was visible through the applied neutral density filter: 3 – densest filter appropriate to age (usually 1.2 log units attenuation), 2 – next densest filter (usually 0.8 log units attenuation), 1 – no filter and 0 – not visible. The summed values were expressed as a percentage of the maximum possible score for that truncated quadrant and the difference from 100% was the visual field loss score. This was repeated for each of the 4 positions shown in Figure 2 and no allowance was made for the presence of the blind spot in the temporal quadrant. From the regression analysis, the value of R2, the coefficient of determination, was obtained. This gives as a percentage the amount of the variation in contrast threshold against visual field loss score which is accounted for by the line of best fit (regression line); so R2 ranges from 0% when the data are randomly distributed to 100% when the data points fall exactly on the regression line. The value of R2 is amenable to statistical testing and significance was taken as p < 0.05.

Results

Control group

The contrast thresholds for the 64 normal eyes were normally uniformly low for each of the superior, temporal, inferior and nasal truncated quadrants with no significant differences between the mean values of the 4 quadrants (p = 0.81). The mean contrast threshold and the 95% upper prediction limit were then calculated for the 4 truncated quadrants for the normal eyes of the group of 8 subjects together with one eye chosen at random from the remaining 28 subjects to give equal numbers of left and right eyes. The contrast threshold values for the group conformed closely to a normal distribution and had a mean value of 0.027 ± 0.011 S.D. contrast units, giving a 95% upper prediction limit of 0.045 contrast units. Inter-ocular comparisons were made between the mean values for left and right eyes in the group of 28 subjects with 2 normal eyes. The mean of the modulus of the difference was 0.0029 ± 0.0020 S.D. contrast units, giving a 95% upper prediction limit of 0.0060 contrast units. These upper prediction limits were then used to assess the contrast thresholds of the glaucoma patients and of the abnormal eyes of the non-glaucoma group.

The Humphrey Central 24-2 test for the 40 normal eyes in 23 subjects (the remaining 6 eyes had non-glaucomatous abnormalities), missed 5 blindspots, gave mean deviations outside normal limits in 8 eyes and gave abnormal or borderline results with the glaucoma hemifield test in 12 eyes. In all cases, the abnormal results were explained by drooping eyelids, obstruction by spectacles or trial frames and subject error, which are common hazards of automated perimetry [32].

Glaucoma patients

The first comparison was to determine the extent to which the contrast threshold for a truncated quadrant exceeded the upper prediction limit of 0.045 contrast units, irrespective of the location of the quadrant. Abnormally high values occurred in 29 out of 33 glaucomatous eyes (87%) and, on a patient by patient basis, in 20 out of 21 patients (95%). There were no apparent differences among the different types of glaucoma (Table 1). Examples of patients with elevated contrast thresholds are shown in Figures 3 &4.

Figure 3.

Figure 3

Open in a new tab

Patient 9 (Table 1) A & B Histograms of contrast threshold (mean S.E.M.) for superior (s), temporal (t), inferior (i) and nasal (n) truncated quadrants in the left and right eyes showing upper 95% prediction limit of 0.045 contrast units as broken horizontal line. Contrast thresholds were abnormal in the left eye. C & D Friedmann visual fields showing: unmarked letters-normal detection (1.2 logarithmic units attenuation), reduced sensitivity (○ 0.8 logarithmic units attenuation and ø zero attenuation) and ● zero detection. The main visual field loss was in the inferior hemifield of the left eye. E Contrast threshold against visual field loss score taken from Friedmann charts for each truncated quadrant, showing best fitting relationship as broken line. Relationship was significant: R2 = 85%, p = 0.001.

Figure 4.

Figure 4

Open in a new tab

Patient 6. Same conventions as in Figure 3 but with ○ as 1.0 logarithmic units attenuation. A & B Contrast thresholds were abnormal in left and right eyes. C & D Visual field loss was diffuse in the left eye and occurred in inferior temporal quadrant of right eye. E Relationship between contrast threshold and visual field loss score was not significant: R2 = 25%, p = 0.12.

Second, a comparison was made of the modulus of the inter-ocular difference of the mean contrast threshold for left and right eyes against the upper prediction limit of 0.0060 contrast units. This was abnormally high in 18 out of 20 glaucoma patients (90%) for whom the comparison was possible, including the patient with bilateral normal contrast thresholds. However, when identification was made on the basis of the combination of either an abnormal contrast threshold or abnormal inter-ocular difference, 100% correct identification was achieved. The optimal sensitivity and specificity and the area under the ROC curve are given in Table 2 which also shows data for tests of contrast threshold restricted to the superior and inferior truncated quadrants and to the nasal and temporal truncated quadrants. Both these assessments show reduced sensitivity compared with testing of all 4 truncated quadrants. It is thus clear contrast threshold elevations, especially in combination with intra-ocular differences were effective in detecting glaucoma.

Table 2.

Signal detection data

Criterion n Sensitivity Specificity Area under ROC
CTmax by eye 33 93.9% 91.0% 0.956
CTmax S/I 33 87.8% 91.0% 0.953
CTmax N/T 33 81.8% 91.0% 0.923
CTmax by patient 21 90.4% 95.0% 0.954
I-O diff 20 89.5% 85.7% 0.897
CTmax or I-O diff 20 95.0% 100% 0.993
Open in a new tab

CTmax highest contrast threshold value, S/I superior and inferior truncated quadrants, N/T nasal and temporal truncated quadrants, I-O diff inter-ocular difference.

OHT patients

In the 5 OHT patients, contrast thresholds were elevated in 4 out of 10 eyes, corresponding to 2 patients, with no differences between those with and without pathological cupping of the optic disc. The inter-ocular difference was elevated in 3 out of 5 OHT patients. Follow-up of the OHT patients over the next 12 months showed that those with normal contrast thresholds retained normal visual fields while the 2 patients with elevated thresholds developed marked visual field loss in both eyes (Table 1).

Comparison of locations of contrast threshold elevation and visual field loss

Our main assessment was to determine whether those parts of the visual field which showed abnormally high contrast thresholds also corresponded to the location of the visual field loss. This was undertaken by regression analysis of contrast threshold against the corresponding visual field loss score for each of the truncated quadrants in both eyes. In order to achieve a reasonable distribution of data points, patients were required to have a range of visual field loss scores in excess of 20% together with an absence of visibility in no more than one of the truncated quadrants. This provided 18 glaucoma patients whose results are shown in Table 1. Contrast threshold and visual field loss were strongly related in 5 patients (R2 = 55–85%, p < 0.05) as illustrated by Figure 3, showed a semblance of s direct relationship in 4 patients (R2 = 46–49%, 0.05 <p < 0.10) and showed an absence of a relationship in 9 patients (R2 = 0–26%, p > 0.1) as illustrated by Figure 4. There was no correlation between the form of the relationship and the type of glaucoma (Table 1). We also repeated the analysis in 8 patients with minimal visual field loss in one eye for which a single mean value was calculated (i.e. giving n = 5 for regression analysis). The R2 values were unaffected in the new analysis (p = 0.84, paired t-test) and a significant or borderline relationship was still present in 5 patients.

Control subjects with abnormal fellow eye

There were 8 subjects in the non-glaucoma control group with an abnormality of one eye. In the subject with the retinal scar, the contrast thresholds were elevated in the truncated quadrant containing the scar as confirmed by the Humphrey Visual Field. On the other hand, the contrast thresholds for the subjects with repaired retinal detachment, mild cataract and solar damage and for 2 amblyopes were normal. The third amblyope had abnormally high contrast thresholds while the subject with macular degeneration was unable to fixate with that eye.

Discussion

Contrast thresholds were readily measured with our Maxwellian view interferometer in normal subjects, even in the presence of refractive errors as large as -7.00 DS and +5.00 DC, which is a positive advantage over externally viewed displays which depend on the accuracy of the refraction and factors like spectacle slippage or obstruction by the edges of frames. In a limited number of cases, contrast thresholds were readily obtained in the presence of minor lens opacities and in amblyopes, though the method is impracticable in cases where fixation cannot be achieved. Generally, the contrast thresholds of normal subjects were uniformly low. While evidence of the blind spot in the form of elevated contrast thresholds in the temporal truncated quadrant occurred infrequently, this was probably the result of stimulation of a large area of retina compared with the well circumscribed extent of the blind spot of which there is a perceptual lack of awareness [33]. The use of relatively large truncated quadrants may suggest intuitively that localisation of visual loss was being sacrificed though there is evidence to suggest that this is not the case. Threshold values between neighbouring test points tend to be correlated with the result that the central visual field is organized into discrete clusters or sectors which are related to the projection of retinal ganglion cell axons [34,35]. Another issue is the variation in the number of cycles between superior/inferior and nasal/temporal truncated quadrants. We chose the stimulus spatial frequency to be 1.0 c deg-1 to ensure high sensitivity in the peripheral retina [26] and a number of cycles which did not limit sensitivity, at least for foveal viewing [36]. It is conceivable that, at a peripheral location, differences in the number of cycles may affect contrast sensitivity though such an effect is likely to be small [37]. Frequency Doubling Technology (FDT) perimetry employs stimulus fields not dissimilar to those employed in the present study though the grating pattern is phase modulated at a high temporal frequency to produce an illusory doubling of the spatial frequency [38]. Reduction of the dimension of the square stimulus field from 10° to 4° produced only a modest increase in contrast threshold [39]. These results are thus not inconsistent with the absence of a significant differences between the contrast thresholds for the different truncated quadrants.

In terms of correct identification of our glaucoma patients, contrast thresholds were elevated in one or more truncated quadrants in all but one of our 21 patients while inter-ocular differences were elevated in all but 2 out of 20 patients, which is consistent with previous studies [4,15-18,21]. These elevations were present irrespective of the type of glaucoma, which is consistent with a common mechanism for ganglion cell loss in chronic glaucoma [40]. In terms of detection of glaucoma, our method has performed soundly with an area under the ROC curve of 0.956 which compares well with other methodologies employed in the early detection of glaucoma viz. short wave length automated perimetry (SWAP), frequency doubling technology, resolution acuity perimetry, detection acuity perimetry and temporal modulation perimetry [41] and considerably better than for contrast sensitivities with central viewing [42]. Of especial interest was the performance of our test with the OHT patients. Initially, it seemed that two patients would be incorrectly diagnosed in both eyes which had markedly elevated contrast thresholds; however within the next 12 months they each developed appreciable visual field loss in their eyes (Table 1). While the sample size is small, it indicates a potential predictive function which has also been described for FDT, high-pass resolution perimetry and SWAP [43,44]. A further improvement in the area under the ROC curve to 0.993 occurred when the assessment of contrast thresholds was combined with that of the inter-ocular difference in contrast threshold. This is a simple extension of the analysis which uses pre-existing data and its value has been remarked upon previously [38].

The central aim of our study, however, was whether the contrast threshold results reflected the amount of visual field loss in the same region of the visual field. While there was a reasonable correspondence in 50% of our 18 glaucoma patients (Figure 3), in the other half of the patients, there was a marked mismatch so that some patients had normal contrast thresholds in quadrants showing high visual field loss while others had elevated contrast thresholds in seemingly normal parts of the visual field (Figure 4). We are confident that the results were not caused by abrupt shifts of visual field loss between quadrants since the visual fields were stable over the 2 years preceding our tests and indeed subsequent to our tests. While automated perimetry is widely used to ascertain visual field loss, our preference was firmly for the Friedmann test on the basis that it was less disconcerting to elderly patients and is consistent with the transferability of visual field data between different machines [45]. While our identification of the misalignment with visual field loss relates to the detection of a stationary grating pattern, allusions have also been made to FDT error scores which occurred in the hemifield opposite to that containing the visual field loss [46,47]. This lack of correspondence between contrast threshold elevation and visual field loss can reasonably be attributed to the different attrition rates for the different modalities of visual function in different individuals which is well known in glaucoma [12,38,48-53]. To this, we can further add that different modalities, at least in terms of light detection and contrast detection, are affected differently in different parts of the retina. The sentiment has been expressed that it does not matter whether two tests do not agree so long as the disease is detected during screening [47]. To an extent this is understandable though it would clearly be desirable to have a rational basis for whatever testing regime is adopted. One possible explanation is that conventional perimetry detects light detection defects [54] while tests like FDT, SWAP and contrast threshold measurements detect different manifestations of ganglion cell damage [40,41]. Certainly there are several tests, particularly FDT and SWAP, which could be used profitably alongside visual field testing [48] and, to these, contrast threshold determinations in the peripheral visual field may be added.

Conclusion

Our results therefore do confirm that contrast thresholds in response to sinusoidal grating patterns presented to peripheral regions of the visual field are invariably abnormally elevated in cases of glaucomatous visual field loss. The regions of threshold elevations, however, did not map onto the regions of visual field loss, which indicates contrast threshold testing cannot be considered as a substitute for visual field tests. It may however provide valuable supplementary information which may be obtained simply and rapidly with the type of interferometric apparatus we have described.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

JLJ carried out the clinical examination of the patients. The scientific experiments were carried out and analyzed by CMT, JSM and JDM who also undertook the construction of the apparatus and drafting of the manuscript which all authors approved.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2415/5/22/prepub

Acknowledgments

Acknowledgements

Our appreciation is expressed to our subjects and patients for their participation in the experiments. We especially thank Mr. W.H. Biddlecombe for manufacturing the Maxwellian lens housing. We also thank Dr. T. Maddess for his detailed comments on the manuscript and the W.H. Ross Foundation for the Prevention of Blindness for financial support.

Contributor Information

CM Tochel, Email: jdm1u@udcf.gla.ac.uk.

JS Morton, Email: jdm1u@udcf.gla.ac.uk.

JL Jay, Email: jdm1u@udcf.gla.ac.uk.

JD Morrison, Email: jdm1u@udcf.gla.ac.uk.

References

  1. Aulhorn E, Karmeyer H. Frequency distribution in early glaucomatous visual field defects. Doc Ophthalmol Proc Ser. 1977;14:75–83. [Google Scholar]
  2. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibres. Ophthalmology. 1988;95:357–363. doi: 10.1016/s0161-6420(88)33176-3. [DOI] [PubMed] [Google Scholar]
  3. Arden GB, Jacobson JJ. A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma. Invest Ophthalmol. 1978;17:23–32. [PubMed] [Google Scholar]
  4. Atkin A, Wolkstein M, Bodis-Wollner I, Anders M, Kels B, Podos SM. Interocular comparisons of contrast sensitivities in glaucoma patients and suspects. Br J Ophthalmol. 1980;64:858–862. doi: 10.1136/bjo.64.11.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Isayama Y, Mizokami K, Tagami Y. Spatial contrast sensitivity in optic nerve disorders. Its relationship to the visual fields and atrophy of retinal nerve fibre layer. Jap J Ophthalmol. 1980;34:293–300. [Google Scholar]
  6. Tagami Y, Onuma T, Mizokami K, Isayama Y. Comparison of spatial contrast sensitivity with visual field in optic neuropathy and glaucoma. Doc Ophthalmol Proc Ser. 1981;26:147–154. [Google Scholar]
  7. Hitchings RA, Powell DJ, Arden GB, Carter RM. Contrast sensitivity gratings in glaucoma family screening. Br J Ophthalmol. 1981;65:515–517. doi: 10.1136/bjo.65.8.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Vaegan , Halliday BL. A forced choice test improves clincal contrast sensitivity testing. Br J Ophthalmol. 1982;66:477–491. doi: 10.1136/bjo.66.8.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ross JE, Bron AJ, Clarke DD. Contrast sensitivity and visual disability in chronic simple glaucoma. Br J Ophthalmol. 1984;68:821–827. doi: 10.1136/bjo.68.11.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Motolko MA, Phelps CD. Contrast sensitivity in asymmetric glaucoma. Int Ophthalmol. 1984;7:45–50. doi: 10.1007/BF00138269. [DOI] [PubMed] [Google Scholar]
  11. Lustgarten JS, Marx MS, Podos SM, Bodis-Wollner I, Campeas D, Serle JB. Contrast sensitivity and computerised perimetry in early detection of glauco-matous change. Clin Vis Sci. 1990;5:407–413. [Google Scholar]
  12. Teoh SL, Allan D, Dutton GN, Foulds WS. Brightness discrimination and contrast sensitivity in chronic glaucoma – a clinical study. Br J Ophthalmol. 1990;74:215–9. doi: 10.1136/bjo.74.4.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sponsel WE, DePaul KL, Martone JF, Shields MB, Ollie AR, Stewart WC. Association of Vistech contrast sensitivity and visual field findings in glaucoma. Br J Ophthalmol. 1991;75:558–60. doi: 10.1136/bjo.75.9.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Swindale NV, Fendick MG, Drance SM, Graham SL, Hnik P. Contrast sensitivity for flickering and static latters at isoluminance in glaucoma. J Glaucoma. 1996;5:156–169. [PubMed] [Google Scholar]
  15. Lundh BL, Lennerstrand G. Eccentric contrast sensitivity loss in glaucoma. Acta Ophthalmologica. 1981;59:21–24. doi: 10.1111/j.1755-3768.1981.tb06705.x. [DOI] [PubMed] [Google Scholar]
  16. Neima D, Leblanc R, Regan D. Visual field defects in ocular hypertension and glaucoma. Arch Ophthalmol. 1984;102:1042–1045. doi: 10.1001/archopht.1984.01040030844029. [DOI] [PubMed] [Google Scholar]
  17. Lundh BL. Central and peripheral contrast sensitivity for static and dynamic sinusoidal gratings in glaucoma. Acta Ophthalmologica. 1985;63:487–492. doi: 10.1111/j.1755-3768.1985.tb05233.x. [DOI] [PubMed] [Google Scholar]
  18. Falcão-Reis F, O'Donoghue E, Buceti R, Hitchings RA, Arden GB. Peripheral contrast sensitivity in glaucoma and ocular hypertension. Br J Ophthalmol. 1990;74:712–716. doi: 10.1136/bjo.74.12.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zulauf M, Flammer M. Correlation of spatial contrast sensitivity and visual fields in glaucoma. Graefe's Arch Clin Exp Ophthalmol. 1993;231:146–150. doi: 10.1007/BF00920937. [DOI] [PubMed] [Google Scholar]
  20. Horn FK, Korth M, Martus P. Quick full field flicker test in glaucoma diagnosis: correlations with perimetry and papillometry. J Glaucoma. 1994;3:206–13. [PubMed] [Google Scholar]
  21. Lundh BL, Gottvall E. Peripheral contrast sensitivity for dynamic sinusoidal gratings in early glaucoma. Acta Ophthalmol Scand. 1995;73:202–206. doi: 10.1111/j.1600-0420.1995.tb00269.x. [DOI] [PubMed] [Google Scholar]
  22. Ansari EA, Morgan JE, Snowden RJ. Psychophysical characterisation of early functional loss in glaucoma and ocular hypertension. Br J Ophthalmol. 2002;86:1131–1135. doi: 10.1136/bjo.86.10.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tochel CM, Jay JL, Morrison JD. Comparison of contrast thresholds and brightness discrimination between visual quadrants and hemifields in normal and glaucomatous subjects. J Physiol. 1999;521:8–9P. [Google Scholar]
  24. Morrison JD, McGrath C. Assessment of the optical contributions to the age-related deterioration in vision. Quart J Exp Physiol. 1985;70:249–269. doi: 10.1113/expphysiol.1985.sp002907. [DOI] [PubMed] [Google Scholar]
  25. Webb RM, Sahal A, Morrison JD. The optical quality of the human eye revisited. Ophthal Physiol Opt. 1997;17:516–21. doi: 10.1016/S0275-5408(97)00046-X. [DOI] [PubMed] [Google Scholar]
  26. Kelly DH. Retinal inhomogeneity. I Spatiotemporal contrast sensitivity. J Opt Soc Am A. 1984;1:107–113. doi: 10.1364/josaa.1.000107. [DOI] [PubMed] [Google Scholar]
  27. Morrison JD, Reilly J. An assessment of decision-making as a possible factor in the age-related loss of contrast sensitivity. Perception. 1986;15:541–552. doi: 10.1068/p150541. [DOI] [PubMed] [Google Scholar]
  28. Ryan BE, Joiner BL. Minitab Handbook. 3. Belmont, California: Duxbury Press; 1994. [Google Scholar]
  29. Stanislaw H, Todorov N. Calculation of signal detection measures. Behav Res Meth Instr Comp. 1999;31:137–149. doi: 10.3758/bf03207704. [DOI] [PubMed] [Google Scholar]
  30. Cello KE, Nelson-Quigg J, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous field loss. Am J Ophthalmol. 2000;129:314–322. doi: 10.1016/S0002-9394(99)00414-6. [DOI] [PubMed] [Google Scholar]
  31. Sponsel WE. Thesis M572. Bristol University; 1985. Visual field quantification in the diagnosis and assessment of chronic open angle glaucoma. [Google Scholar]
  32. Anderson DR. Standard perimetry. Ophthalmol Clin N Am. 2003;16:205–212. doi: 10.1016/S0896-1549(03)00005-1. [DOI] [PubMed] [Google Scholar]
  33. Ramachandran VS. Blind spots. Sci Am. 1972;266:44–49. doi: 10.1038/scientificamerican0592-86. [DOI] [PubMed] [Google Scholar]
  34. Suzuki Y, et al. Mathematical and optimal clustering of test points of the central 30-degree visual field of glaucoma. J Glaucoma. 2001;10:121–128. doi: 10.1097/00061198-200104000-00009. [DOI] [PubMed] [Google Scholar]
  35. De la Rosa MG, González-Hernández M, Abraldes M, Azuara-Blanco A. Quantification of interpoint topographic correlations of threshold values in glaucomatous visual fields. J Glaucoma. 2002;11:30–34. doi: 10.1097/00061198-200202000-00007. [DOI] [PubMed] [Google Scholar]
  36. Hoekstra J, Van Der Goot DPJ, Van Den Brink G, Bilsen FA. The influence of the number of cycles upon the visual contrast threshold for spatial sine wave patterns. Vis Res. 1973;14:365–368. doi: 10.1016/0042-6989(74)90234-X. [DOI] [PubMed] [Google Scholar]
  37. Robson JG, Grahan N. Probability summation and regional variation in contrast sensnitivity across the visual field. Vis Res. 1981;21:409–418. doi: 10.1016/0042-6989(81)90169-3. [DOI] [PubMed] [Google Scholar]
  38. Maddess T, Goldberg I, Dobinson J, Wine S, Welsh AH, James AC. Testing for glaucoma with spatial frequency doubling illusion. Vis Res. 1999;39:4258–4273. doi: 10.1016/S0042-6989(99)00135-2. [DOI] [PubMed] [Google Scholar]
  39. Spry PGD, Johnson CA. Within-test variability of frequency-doubling perimetry using a 24-2 test pattern. J Glaucoma. 2002;11:315–320. doi: 10.1097/00061198-200208000-00007. [DOI] [PubMed] [Google Scholar]
  40. Quigley HA. Neuronal death in glaucoma. Prog Retinal Eye Res. 1999;18:39–57. doi: 10.1016/S1350-9462(98)00014-7. [DOI] [PubMed] [Google Scholar]
  41. Spry PGD, Johnson CA, Mansberger SL, Cioffi GA. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma. 2005;14:11–19. doi: 10.1097/01.ijg.0000145813.46848.b8. [DOI] [PubMed] [Google Scholar]
  42. Ivers RQ, Macaskill P, Cumming RG, Mitchell P. Sensitivity and specificity of tests to detect eye disease in an older population. Ophthalmology. 2001;108:968–975. doi: 10.1016/S0161-6420(00)00649-7. [DOI] [PubMed] [Google Scholar]
  43. Iester M, Altieri M, Vittione P, Calabria G, Zingirian M, Traverso CE. Detection of glaucomatous visual field defect by nonconventional perimetry. Am J Ophthalmol. 2003;135:35–39. doi: 10.1016/S0002-9394(02)01818-4. [DOI] [PubMed] [Google Scholar]
  44. Landers JA, Goldberg I, Graham SL. Detection of early visual field loss in glaucoma using frequency-doubling perometry and short-wavelength automated perimetry. Arch Ophthalmol. 2003;121:1705–1710. doi: 10.1001/archopht.121.12.1705. [DOI] [PubMed] [Google Scholar]
  45. Anderson DR, Feuer WJ, Alward WL, Skuta GL. Threshold equivalence between perimeters. Am J Ophthalmol. 1989;83:1396–1402. doi: 10.1016/0002-9394(89)90493-5. [DOI] [PubMed] [Google Scholar]
  46. Quigley HA. Identification of glaucoma-related abnormality with screening protocol of frequency doubling technology. Am J Ophthalmol. 1998;125:819–829. doi: 10.1016/S0002-9394(98)00046-4. [DOI] [PubMed] [Google Scholar]
  47. Allen CS, Sponsel WE, Trigo Y, Dirks MS, Flynn WJ. Comparison of the frequency doubling technology screening algorithm and the Humphrey 24-2 SITA-FAST in a large eye screening. Clin Exp Ophthalmol. 2002;30:8–14. doi: 10.1046/j.1442-9071.2002.00478.x. [DOI] [PubMed] [Google Scholar]
  48. Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparisons of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1783–1790. [PubMed] [Google Scholar]
  49. Anderson RS, O'Brien C. Psychophysical evidence for a selective loss of M ganglion cells in glaucoma. Vis Res. 1989;15:493–505. doi: 10.1016/s0042-6989(96)00260-x. [DOI] [PubMed] [Google Scholar]
  50. Bosworth CF, Sample PA, Gupta N, Bathija R, Weinreb RN. Motion automated perimetry (MAP) identifies early glaucomatous field defects. Arch Ophthalmol. 1998;116:1153–8. doi: 10.1001/archopht.116.9.1153. [DOI] [PubMed] [Google Scholar]
  51. Casson EJ, Johnson CA, Shapiro LR. Longitudinal comparison of temporal-modulation perimetry with white-on-white and blue-on-yellow perimetry in ocular hypertension and early glaucoma. J Opt Soc Am A. 1993;10:1792–1806. doi: 10.1364/josaa.10.001792. [DOI] [PubMed] [Google Scholar]
  52. Pacheco-Cutillas M, Sahraie A, Edgar DF. Acquired colour vision defects in glaucoma – their detection and clinical significance. Br J Ophthalmol. 1999;83:1396–1402. doi: 10.1136/bjo.83.12.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pearson P, Swanson WH, Fellman RL. Chromatic and achromatic defects in patients with progressing glaucoma. Vis Res. 2001;41:1215–1227. doi: 10.1016/S0042-6989(00)00311-4. [DOI] [PubMed] [Google Scholar]
  54. Janssen P, Naskar R, Moore S, Thanos H, Thiel H. Evidence for glaucoma-induced horizontal cell alterations in the human retina. Ger J Ophthalmol. 1997;5:378–385. [PubMed] [Google Scholar]

Articles from BMC Ophthalmology are provided here courtesy of BMC

RESOURCES